Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,328.00
Bid: 12,326.00
Ask: 12,328.00
Change: -36.00 (-0.29%)
Spread: 2.00 (0.016%)
Open: 12,358.00
High: 12,358.00
Low: 12,276.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK sends first of 100 million promised vaccine doses to poorer nations

Wed, 28th Jul 2021 16:35

(Alliance News) - The first batch of excess coronavirus vaccines from Britain will be shipped off to "vulnerable" nations and Commonwealth allies this week, the UK Foreign Secretary has announced.

Leaders of the major industrialised nations at the G7 summit in Cornwall pledged more than one billion doses of Covid-19 vaccine – 870 million jabs shared directly and the rest through funding to the Covax initiative – to poorer countries.

Prime Minister Boris Johnson confirmed the UK's contribution to the one billion dose pledge is another 100 million vaccines from now to next June, with Dominic Raab announcing on Wednesday that the first shipment of nine million spare Oxford-AstraZeneca PLC will be made this week.

And in a message to western countries who have unused stockpiles of AstraZeneca jabs, Raab stressed that bodies ranging from the World Health Organisation to the European Medicines Agency had approved the British-designed vaccine as safe, arguing it was "crucially important" for all nations to vaccinate their populations.

It comes as parts of Australia have been forced to go back into lockdown despite the UK ally having three million unboxed doses of the AstraZeneca inoculation stored, according to reports.

Fears about the Oxford jab's side effects, including an increased risk of blood clots, have seen it shunned in some wealthy countries.

The Foreign Secretary visited an AstraZeneca manufacturing site in Oxford on Wednesday to announce that the first despatch of excess UK doses will be making their way to poorer nations this week – with five million to be distributed via the WHO's Covax scheme and another four million bilaterally.

Speaking to the PA news agency after the visit, the Cabinet minister said: "We succeeded in double-vaccinating 70% of the adult population, the UK economy is bouncing back but we know we're not going to be safe in the UK until everyone is safe.

"That is why we have been leading the (international) vaccine rollout to give enough doses to get the world vaccinated by the middle of next year, rather than the current trajectory, which is the end of 2024."

Raab said the UK was delivering on its G7 pledge of sending 100 million surplus vaccines to the "poorest and most vulnerable countries around the world" before the middle of 2022.

"The first nine million doses will be going on Friday to countries from vulnerable countries in the Indo-Pacific, such as Laos, Cambodia, key partners like Indonesia, right the way through the Commonwealth countries from Kenya to Jamaica," the Cabinet minister added.

"I think what it shows, as well as the domestic rollout and the importance of coming out of the lockdowns in the UK, is that global Britain is also a lifesaving force for good in the world."

Indonesia will receive 600,000 doses of those being handed out bilaterally, 300,000 will be sent to Jamaica and 817,000 are to be transported to Kenya, among other countries, the Foreign Office said.

Raab, who is also First Secretary of State, joined the prime minister and fellow Cabinet colleague Therese Coffey in refusing to repeat Michael Gove's assertion that it was "selfish" to refuse a vaccine.

The Chancellor of the Duchy of Lancaster's comment comes as the government prepares to make being double-jabbed a condition of entry to nightclubs in September in a bid to increase the number of young people coming forward for inoculation.

Asked what he made of Gove's remark, Raab told PA: "Look, I think people should get vaccinated for their own self-interest because it is far safer to do so, and I would encourage everyone to do so."

Professor Sir John Bell said the UK's decision to send unneeded Covid-19 vaccines to developing nations was "long overdue" and would help guard against new variants of the virus forming.

The Regius Professor of Medicine at Oxford University told BBC Radio 4's World At One programme: "I think it is a bit self-indulgent, to be honest, of western countries fretting about these kinds of issues (what rights to afford the fully vaccinated) when the vast majority of the globe remains completely unvaccinated, with massive levels of viral replication sweeping through the population.

"If you want variants, you've got the perfect storm for that, and it is not in Watford – it is in Zimbabwe and Rwanda and South Africa."

By Patrick Daly, PA Political Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.